Truist Financial’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,145
Closed -$19.6K 2666
2025
Q1
$19.6K Hold
13,145
﹤0.01% 2528
2024
Q4
$14.7K Buy
+13,145
New +$11.2K ﹤0.01% 2500
2023
Q1
Sell
-10,762
Closed -$16.4K 2648
2022
Q4
$16.4K Buy
+10,762
New +$18.5K ﹤0.01% 2534
2022
Q3
Sell
-11,373
Closed -$15K 2637
2022
Q2
$15K Buy
+11,373
New +$16.9K ﹤0.01% 2608

Other funds holding PGEN

Truist Financial's PGEN Position: Q2 2025 in Review

Truist Financial sold out of Precigen (PGEN) in Q2 2025, closing a stake of 13,145 shares — an estimated $19.6K sold.

Truist Financial first reported a position in PGEN in Q2 2022 and held it in 4 quarters. The position peaked at $19.6K in Q1 2025. 147 funds tracked by Wall St. Rank hold PGEN as of Q2 2025.

  • Truist Financial reported no remaining Precigen position as of Q2 2025 after selling out during the quarter.
  • Truist Financial sold 13,145 Precigen shares in Q2 2025, an estimated $19.6K.
  • Truist Financial first reported a position in Precigen in Q2 2022 and held it in 4 quarters.
  • Truist Financial's Precigen position peaked at $19.6K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Precigen as of Q2 2025.

Based on Truist Financial's 13F filing for Q2 2025, filed 18 Jul 2025.